We got a huge clue from Leo referencing big deals for other psoriasis drugs. If you were trying to bury awareness of your company's new psoriasis drug, would you post comparisons of big deals for other drugs -- hey, my drug doesn't work, this is what we missed out on? Of course not.

Also, the fact that they are going to release raw data means that they are confident of the results. We have seen other companies release raw data that THEY thought was good, but the stock tanked because the raw data did not make it clear that the company's drug worked on a SUBSET of the patients, so people drew the wrong conclusion that it didn't work at all. Leo is not stupid and uninformed, and he and the rest of them at CTIX would not be releasing the data unless it was clear-cut as to efficacy.